Free Trial

Dynatronics (DYNT) Competitors

Dynatronics logo
$0.14 +0.03 (+31.58%)
As of 03/26/2025 02:17 PM Eastern

DYNT vs. NAOV, HSCS, TNON, GCTK, BBLG, TTOO, NDRA, BJDX, TIVC, and VERO

Should you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include NanoVibronix (NAOV), Heart Test Laboratories (HSCS), Tenon Medical (TNON), GlucoTrack (GCTK), Bone Biologics (BBLG), T2 Biosystems (TTOO), ENDRA Life Sciences (NDRA), Bluejay Diagnostics (BJDX), Tivic Health Systems (TIVC), and Venus Concept (VERO). These companies are all part of the "medical equipment" industry.

Dynatronics vs.

NanoVibronix (NASDAQ:NAOV) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, community ranking, media sentiment, valuation and risk.

Dynatronics has a net margin of -8.35% compared to NanoVibronix's net margin of -93.80%. Dynatronics' return on equity of -41.81% beat NanoVibronix's return on equity.

Company Net Margins Return on Equity Return on Assets
NanoVibronix-93.80% -101.17% -53.03%
Dynatronics -8.35%-41.81%-9.56%

NanoVibronix has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500.

In the previous week, NanoVibronix had 4 more articles in the media than Dynatronics. MarketBeat recorded 4 mentions for NanoVibronix and 0 mentions for Dynatronics. NanoVibronix's average media sentiment score of 0.62 beat Dynatronics' score of 0.00 indicating that NanoVibronix is being referred to more favorably in the media.

Company Overall Sentiment
NanoVibronix Positive
Dynatronics Neutral

Dynatronics received 238 more outperform votes than NanoVibronix when rated by MarketBeat users. However, 57.26% of users gave NanoVibronix an outperform vote while only 47.54% of users gave Dynatronics an outperform vote.

CompanyUnderperformOutperform
NanoVibronixOutperform Votes
71
57.26%
Underperform Votes
53
42.74%
DynatronicsOutperform Votes
309
47.54%
Underperform Votes
341
52.46%

16.4% of NanoVibronix shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 7.0% of NanoVibronix shares are owned by insiders. Comparatively, 8.0% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Dynatronics has higher revenue and earnings than NanoVibronix. NanoVibronix is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NanoVibronix$3.29M0.93-$3.71M-$13.53-0.29
Dynatronics$33.60M0.04-$2.70M-$0.82-0.16

Summary

Dynatronics beats NanoVibronix on 9 of the 15 factors compared between the two stocks.

Remove Ads
Get Dynatronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYNT vs. The Competition

MetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.19M$4.42B$5.63B$8.13B
Dividend YieldN/A32.62%4.55%4.00%
P/E Ratio-0.1628.7924.4919.08
Price / Sales0.0449.55385.3094.72
Price / CashN/A51.0838.1634.64
Price / Book0.246.166.954.36
Net Income-$2.70M$67.64M$3.20B$247.23M
7 Day Performance4.65%-1.28%-2.19%-0.32%
1 Month Performance22.73%0.35%3.13%-3.60%
1 Year Performance-69.83%16.42%11.28%2.01%

Dynatronics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYNT
Dynatronics
N/A$0.14
+31.6%
N/A-69.6%$1.19M$33.60M-0.16200Analyst Forecast
Gap Up
NAOV
NanoVibronix
0.7415 of 5 stars
$4.25
-3.2%
N/A-61.9%$3.37M$3.29M-3.4620Short Interest ↓
Gap Down
HSCS
Heart Test Laboratories
2.8172 of 5 stars
$2.96
+1.7%
$13.00
+339.2%
-75.4%$3.20M$14,700.00-0.3710Gap Up
TNON
Tenon Medical
1.6391 of 5 stars
$0.98
-2.2%
$5.50
+462.3%
+153.4%$3.07M$3.32M-0.048Short Interest ↑
News Coverage
Gap Down
High Trading Volume
GCTK
GlucoTrack
1.3208 of 5 stars
$0.27
-9.5%
N/A-99.3%$2.81MN/A0.005Short Interest ↓
High Trading Volume
BBLG
Bone Biologics
1.206 of 5 stars
$0.85
-3.4%
N/A-59.7%$2.78MN/A0.002Short Interest ↓
TTOO
T2 Biosystems
N/A$0.12
+4.1%
$5.00
+4,005.1%
-95.6%$2.56M$7.68M0.00180Analyst Forecast
News Coverage
NDRA
ENDRA Life Sciences
2.0308 of 5 stars
$4.49
+4.4%
$700,000.00
+15,590,100.4%
-100.0%$2.41MN/A0.0020Short Interest ↑
BJDX
Bluejay Diagnostics
1.2064 of 5 stars
$3.93
-6.2%
N/A-98.9%$2.17M$250,000.000.009Short Interest ↓
Gap Down
TIVC
Tivic Health Systems
0.647 of 5 stars
$3.41
-3.9%
N/A-85.3%$2.09M$957,000.000.0010Earnings Report
Short Interest ↓
Positive News
Gap Down
VERO
Venus Concept
0.7615 of 5 stars
$3.11
+0.3%
N/A-57.7%$2.05M$67.20M-0.39410Short Interest ↑
Remove Ads

Related Companies and Tools


This page (NASDAQ:DYNT) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners